Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Formulation and evaluation of Pheroid vesicles containing mefloquine for the treatment of malaria.

du Plessis LH, Helena C, van Huysteen E, Wiesner L, Kotzé AF.

J Pharm Pharmacol. 2014 Jan;66(1):14-22. doi: 10.1111/jphp.12147. Epub 2013 Oct 13.

PMID:
24117456
2.

In vivo efficacy and bioavailability of lumefantrine: Evaluating the application of Pheroid technology.

du Plessis LH, Govender K, Denti P, Wiesner L.

Eur J Pharm Biopharm. 2015 Nov;97(Pt A):68-77. doi: 10.1016/j.ejpb.2015.10.001. Epub 2015 Oct 17.

PMID:
26478276
3.

In vitro activity of Pheroid vesicles containing antibiotics against Plasmodium falciparum.

Du Plessis LH, van Niekerk AC, Maritz MM, Kotzé AF.

J Antibiot (Tokyo). 2012 Dec;65(12):609-14. doi: 10.1038/ja.2012.89. Epub 2012 Oct 24.

PMID:
23093037
4.

Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine.

Steketee RW, Wirima JJ, Slutsker L, Khoromana CO, Heymann DL, Breman JG.

Am J Trop Med Hyg. 1996;55(1 Suppl):50-6.

PMID:
8702037
5.

Clarithromycin enhances the antimalarial efficacy of mefloquine via its increased bioavailability and disrupting P. falciparum apicoplast.

Gunjan S, Singh SK, Chauhan BS, Pandey SK, Ahmad H, Dwivedi AK, Tripathi R.

Life Sci. 2015 Sep 1;136:126-32. doi: 10.1016/j.lfs.2015.06.027. Epub 2015 Jul 9.

PMID:
26164186
6.

Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi.

Steketee RW, Wirima JJ, Slutsker L, Roberts JM, Khoromana CO, Heymann DL, Breman JG.

Am J Trop Med Hyg. 1996;55(1 Suppl):24-32.

PMID:
8702034
7.
8.

Fluoxetine potentiates chloroquine and mefloquine effect on multidrug-resistant Plasmodium falciparum in vitro.

Khairul MF, Min TH, Low JH, Nasriyyah CH, A'shikin AN, Norazmi MN, Ravichandran M, Raju SS.

Jpn J Infect Dis. 2006 Oct;59(5):329-31.

9.

Drug resistance and in vitro susceptibility of Plasmodium falciparum in Thailand during 1988-2003.

Suwandittakul N, Chaijaroenkul W, Harnyuttanakorn P, Mungthin M, Na Bangchang K.

Korean J Parasitol. 2009 Jun;47(2):139-44. doi: 10.3347/kjp.2009.47.2.139. Epub 2009 May 27.

11.

Roxithromycin potentiates the effects of chloroquine and mefloquine on multidrug-resistant Plasmodium falciparum in vitro.

Min TH, Khairul MF, Low JH, Che Nasriyyah CH, A'shikin AN, Norazmi MN, Ravichandran M, Raju SS.

Exp Parasitol. 2007 Apr;115(4):387-92. Epub 2006 Nov 21.

PMID:
17118354
12.

Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru.

Marquiño W, Huilca M, Calampa C, Falconí E, Cabezas C, Naupay R, Ruebush TK 2nd.

Am J Trop Med Hyg. 2003 May;68(5):608-12.

PMID:
12812355
13.
14.

Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru.

Marquiño W, MacArthur JR, Barat LM, Oblitas FE, Arrunátegui M, Garavito G, Chafloque ML, Pardavé B, Gutierrez S, Arróspide N, Carrillo C, Cabezas C, Ruebush TK 2nd.

Am J Trop Med Hyg. 2003 Jan;68(1):120-3.

PMID:
12557836
15.
16.

In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003.

Chaijaroenkul W, Bangchang KN, Mungthin M, Ward SA.

Malar J. 2005 Aug 2;4:37.

17.

Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.

Denoeud-Ndam L, Zannou DM, Fourcade C, Taron-Brocard C, Porcher R, Atadokpede F, Komongui DG, Dossou-Gbete L, Afangnihoun A, Ndam NT, Girard PM, Cot M.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):198-206. doi: 10.1097/QAI.0000000000000058.

PMID:
24220287
18.

Evaluation of the physical properties and stability of two lipid drug delivery systems containing mefloquine.

Slabbert C, Plessis LH, Kotzé AF.

Int J Pharm. 2011 May 16;409(1-2):209-15. doi: 10.1016/j.ijpharm.2011.01.050. Epub 2011 Feb 16.

PMID:
21310223
19.

Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.

Chaijaroenkul W, Wisedpanichkij R, Na-Bangchang K.

Acta Trop. 2010 Feb;113(2):190-4. doi: 10.1016/j.actatropica.2009.10.016. Epub 2009 Oct 30.

PMID:
19879850
20.

Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride.

du Plessis LH, Lubbe J, Strauss T, Kotzé AF.

Int J Pharm. 2010 Jan 29;385(1-2):181-6. doi: 10.1016/j.ijpharm.2009.10.031. Epub 2009 Oct 23.

PMID:
19854253

Supplemental Content

Support Center